Omalizumab in Practice: Ten-Year Experience of A Tertiary Referral Allergy Centre


Oztop N. , Demir S. , Beyaz S. , Tuzer O. C. , Colakoglu B. , Buyukozturk S. , ...More

ASTIM ALLERJI IMMUNOLOJI, 2022 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Publication Date: 2022
  • Doi Number: 10.21911/aai.647
  • Journal Name: ASTIM ALLERJI IMMUNOLOJI
  • Journal Indexes: Emerging Sources Citation Index, TR DİZİN (ULAKBİM)
  • Keywords: Anaphylaxis, ABPA, severe asthma, chronic spontaneous urticaria, mastocytosis, nasal polyposis, omalizumab, BRONCHOPULMONARY ASPERGILLOSIS, ASTHMA, GUIDELINE, THERAPY

Abstract

Objective: To evaluate the clinical outcome of omalizumab in various diseases.